Infectious Disease Diagnostics – News and Features

Company building world’s largest genotype/phenotype database by sequencing up to 40,000 human genomes/year.

Expanded agreement will see Lab21 distribute AnDiaTec’s Real-Time PCR Tests within the UK.

A new approach to influenza testing, that utilises sugar labelled with gold to distinguish between human and avian strains, has been patented by researchers on Norwich Research Park.

DxNA, llc. announced the finalizing of an equity investment of $2.5 million by an individual investor.

Currently, disease usually found too late to save lives.

Initiative combines expertise to accelerate clinical diagnostic screening.

Paving the way for better HIV treatment in the world’s least-developed countries.

As a patient facing illness, knowing what’s ailing you can bring peace of mind and, more importantly, can inform treatment decisions.

With the acquisition of BioFire, bioMérieux consolidates its position as a major player in infectious disease diagnostics.

Company is building momentum in Personalized Healthcare with FDA approval of therascreen EGFR companion diagnostic and new pharma co-development projects.